BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21827791)

  • 1. Secretory expression of all 16 subtypes of the hemagglutinin 1 protein of influenza A virus in insect cells.
    Cui S; Wu C; Zhou H; Zhao R; Guo L; Wang J; Hung T
    J Virol Methods; 2011 Nov; 177(2):160-7. PubMed ID: 21827791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo biotinylated recombinant influenza A virus hemagglutinin for use in subtype-specific serodiagnostic assays.
    Postel A; Letzel T; Müller F; Ehricht R; Pourquier P; Dauber M; Grund C; Beer M; Harder TC
    Anal Biochem; 2011 Apr; 411(1):22-31. PubMed ID: 21172299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of sulphatide to recombinant haemagglutinin of influenza A virus produced by a baculovirus protein expression system.
    Takahashi T; Satoh H; Takaguchi M; Takafuji S; Yokoyama H; Fujii S; Suzuki T
    J Biochem; 2010 Apr; 147(4):459-62. PubMed ID: 20145020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice.
    Hu X; Meng W; Dong Z; Pan W; Sun C; Chen L
    Virus Res; 2011 Jan; 155(1):156-62. PubMed ID: 20883733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls.
    Fouchier RA; Munster V; Wallensten A; Bestebroer TM; Herfst S; Smith D; Rimmelzwaan GF; Olsen B; Osterhaus AD
    J Virol; 2005 Mar; 79(5):2814-22. PubMed ID: 15709000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in response among individuals to antigenic sites on the HA protein of human influenza virus may be responsible for the emergence of drift strains in the human population.
    Nakajima S; Nobusawa E; Nakajima K
    Virology; 2000 Aug; 274(1):220-31. PubMed ID: 10936103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and Characterization of HA1 Protein of Highly Pathogenic H5N1 Avian Influenza Virus for Use in a Serodiagnostic Assay.
    Luo L; Nishi K; MacLeod E; Sabara MI
    Transbound Emerg Dis; 2017 Apr; 64(2):432-441. PubMed ID: 26040437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes.
    Varecková E; Mucha V; Kostolanský F; Gubareva LV; Klimov A
    Virus Res; 2008 Mar; 132(1-2):181-6. PubMed ID: 18037184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual expression of the HA protein of H5N2 avian influenza virus in a baculovirus system.
    Hu YC; Luo YL; Ji WT; Chulu JL; Chang PC; Shieh H; Wang CY; Liu HJ
    J Virol Methods; 2006 Jul; 135(1):43-8. PubMed ID: 16530857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of recombinant HA1 protein for specific detection of influenza A/H1N1/2009 antibodies in human serum.
    Luo L; Nishi K; Macleod E; Sabara MI; Coleman BL; Gubbay JB; Li Y
    Microbiol Immunol; 2013 Jan; 57(1):77-81. PubMed ID: 23126568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically destined potentials for N-linked glycosylation of influenza virus hemagglutinin.
    Igarashi M; Ito K; Kida H; Takada A
    Virology; 2008 Jul; 376(2):323-9. PubMed ID: 18456302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemagglutinin displayed baculovirus protects against highly pathogenic influenza.
    Tang XC; Lu HR; Ross TM
    Vaccine; 2010 Oct; 28(42):6821-31. PubMed ID: 20727393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria.
    Shen S; Mahadevappa G; Oh HL; Wee BY; Choi YW; Hwang LA; Lim SG; Hong W; Lal SK; Tan YJ
    J Med Virol; 2008 Nov; 80(11):1972-83. PubMed ID: 18814259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response.
    Kuwano K; Scott M; Young JF; Ennis FA
    J Immunol; 1988 Feb; 140(4):1264-8. PubMed ID: 2449498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domain-structure of cytoplasmic border region is main determinant for palmitoylation of influenza virus hemagglutinin (H7).
    Ponimaskin E; Schmidt MF
    Virology; 1998 Sep; 249(2):325-35. PubMed ID: 9791024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
    Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
    Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
    Bianchi E; Liang X; Ingallinella P; Finotto M; Chastain MA; Fan J; Fu TM; Song HC; Horton MS; Freed DC; Manger W; Wen E; Shi L; Ionescu R; Price C; Wenger M; Emini EA; Cortese R; Ciliberto G; Shiver JW; Pessi A
    J Virol; 2005 Jun; 79(12):7380-8. PubMed ID: 15919893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies.
    Wang W; Butler EN; Veguilla V; Vassell R; Thomas JT; Moos M; Ye Z; Hancock K; Weiss CD
    J Virol Methods; 2008 Nov; 153(2):111-9. PubMed ID: 18722473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.